Drug use patterns over time among HIV-seropositive and HIV-seronegative women: The HER study experience

Grace E. Macalino, Hyejin Ko, David D. Celentano, Joseph W. Hogan, Ellie Schoenbaum, Paula Schuman, Josiah D. Rich

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: Drug use, particularly among women, is a public health issue given its health effects and its impact on HIV transmission. Becoming HIV seropositive could lead to differing patterns of drug use over time. HIV infection may decrease drug use due to an increased access to health services. Alternatively, increased drug use may occur due to depression associated with being HIV infected, leading to despair, hopelessness, and a lack of motivation to become drug free. Methods: We evaluated the potential association between HIV serostatus and drug use among a cohort of 1310 women who were part of a multicenter collaborative study on the natural history of HIV infection. Eight hundred seventy-one HIV-seropositive women and 439 HIV-seronegative women were enrolled at four sites (New York, Providence, Baltimore, and Detroit). We defined drug use as any heroin or cocaine use reported at the baseline visit (enrollment). Results: Drug use was found to decrease during earlier visits (months 1-24) and remained stable at 20% thereafter (months 30-84). No significant differences in change of drug use were noted by HIV serostatus, using generalized estimating equation-based logistic regression analyses. Conclusions: HIV-seropositive status did not affect drug use patterns over time within our population of high-risk women.

Original languageEnglish (US)
Pages (from-to)500-505
Number of pages6
JournalJournal of Acquired Immune Deficiency Syndromes
Volume33
Issue number4
StatePublished - Aug 1 2003

Fingerprint

HIV
Pharmaceutical Preparations
HIV Infections
Baltimore
Heroin
Cocaine
Multicenter Studies
Health Services
Public Health
Logistic Models
Regression Analysis
Health
Population

Keywords

  • HIV
  • Injection drug use
  • Longitudinal studies
  • Women

ASJC Scopus subject areas

  • Virology
  • Immunology

Cite this

Macalino, G. E., Ko, H., Celentano, D. D., Hogan, J. W., Schoenbaum, E., Schuman, P., & Rich, J. D. (2003). Drug use patterns over time among HIV-seropositive and HIV-seronegative women: The HER study experience. Journal of Acquired Immune Deficiency Syndromes, 33(4), 500-505.

Drug use patterns over time among HIV-seropositive and HIV-seronegative women : The HER study experience. / Macalino, Grace E.; Ko, Hyejin; Celentano, David D.; Hogan, Joseph W.; Schoenbaum, Ellie; Schuman, Paula; Rich, Josiah D.

In: Journal of Acquired Immune Deficiency Syndromes, Vol. 33, No. 4, 01.08.2003, p. 500-505.

Research output: Contribution to journalArticle

Macalino, Grace E. ; Ko, Hyejin ; Celentano, David D. ; Hogan, Joseph W. ; Schoenbaum, Ellie ; Schuman, Paula ; Rich, Josiah D. / Drug use patterns over time among HIV-seropositive and HIV-seronegative women : The HER study experience. In: Journal of Acquired Immune Deficiency Syndromes. 2003 ; Vol. 33, No. 4. pp. 500-505.
@article{57fdbd3da61747fdb9f32593e210e39c,
title = "Drug use patterns over time among HIV-seropositive and HIV-seronegative women: The HER study experience",
abstract = "Background: Drug use, particularly among women, is a public health issue given its health effects and its impact on HIV transmission. Becoming HIV seropositive could lead to differing patterns of drug use over time. HIV infection may decrease drug use due to an increased access to health services. Alternatively, increased drug use may occur due to depression associated with being HIV infected, leading to despair, hopelessness, and a lack of motivation to become drug free. Methods: We evaluated the potential association between HIV serostatus and drug use among a cohort of 1310 women who were part of a multicenter collaborative study on the natural history of HIV infection. Eight hundred seventy-one HIV-seropositive women and 439 HIV-seronegative women were enrolled at four sites (New York, Providence, Baltimore, and Detroit). We defined drug use as any heroin or cocaine use reported at the baseline visit (enrollment). Results: Drug use was found to decrease during earlier visits (months 1-24) and remained stable at 20{\%} thereafter (months 30-84). No significant differences in change of drug use were noted by HIV serostatus, using generalized estimating equation-based logistic regression analyses. Conclusions: HIV-seropositive status did not affect drug use patterns over time within our population of high-risk women.",
keywords = "HIV, Injection drug use, Longitudinal studies, Women",
author = "Macalino, {Grace E.} and Hyejin Ko and Celentano, {David D.} and Hogan, {Joseph W.} and Ellie Schoenbaum and Paula Schuman and Rich, {Josiah D.}",
year = "2003",
month = "8",
day = "1",
language = "English (US)",
volume = "33",
pages = "500--505",
journal = "Journal of Acquired Immune Deficiency Syndromes",
issn = "1525-4135",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Drug use patterns over time among HIV-seropositive and HIV-seronegative women

T2 - The HER study experience

AU - Macalino, Grace E.

AU - Ko, Hyejin

AU - Celentano, David D.

AU - Hogan, Joseph W.

AU - Schoenbaum, Ellie

AU - Schuman, Paula

AU - Rich, Josiah D.

PY - 2003/8/1

Y1 - 2003/8/1

N2 - Background: Drug use, particularly among women, is a public health issue given its health effects and its impact on HIV transmission. Becoming HIV seropositive could lead to differing patterns of drug use over time. HIV infection may decrease drug use due to an increased access to health services. Alternatively, increased drug use may occur due to depression associated with being HIV infected, leading to despair, hopelessness, and a lack of motivation to become drug free. Methods: We evaluated the potential association between HIV serostatus and drug use among a cohort of 1310 women who were part of a multicenter collaborative study on the natural history of HIV infection. Eight hundred seventy-one HIV-seropositive women and 439 HIV-seronegative women were enrolled at four sites (New York, Providence, Baltimore, and Detroit). We defined drug use as any heroin or cocaine use reported at the baseline visit (enrollment). Results: Drug use was found to decrease during earlier visits (months 1-24) and remained stable at 20% thereafter (months 30-84). No significant differences in change of drug use were noted by HIV serostatus, using generalized estimating equation-based logistic regression analyses. Conclusions: HIV-seropositive status did not affect drug use patterns over time within our population of high-risk women.

AB - Background: Drug use, particularly among women, is a public health issue given its health effects and its impact on HIV transmission. Becoming HIV seropositive could lead to differing patterns of drug use over time. HIV infection may decrease drug use due to an increased access to health services. Alternatively, increased drug use may occur due to depression associated with being HIV infected, leading to despair, hopelessness, and a lack of motivation to become drug free. Methods: We evaluated the potential association between HIV serostatus and drug use among a cohort of 1310 women who were part of a multicenter collaborative study on the natural history of HIV infection. Eight hundred seventy-one HIV-seropositive women and 439 HIV-seronegative women were enrolled at four sites (New York, Providence, Baltimore, and Detroit). We defined drug use as any heroin or cocaine use reported at the baseline visit (enrollment). Results: Drug use was found to decrease during earlier visits (months 1-24) and remained stable at 20% thereafter (months 30-84). No significant differences in change of drug use were noted by HIV serostatus, using generalized estimating equation-based logistic regression analyses. Conclusions: HIV-seropositive status did not affect drug use patterns over time within our population of high-risk women.

KW - HIV

KW - Injection drug use

KW - Longitudinal studies

KW - Women

UR - http://www.scopus.com/inward/record.url?scp=0038298319&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038298319&partnerID=8YFLogxK

M3 - Article

C2 - 12869839

AN - SCOPUS:0038298319

VL - 33

SP - 500

EP - 505

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

SN - 1525-4135

IS - 4

ER -